Home
Sitemap
Contact Us
KOR
About PGRC
Research
Acivity
Product
Service
Board
×
About RGRC
Message
Introduction
History
Organization
Members
Research Facilities
Research
Clinical Pharmacology
Genomics
Proteomics
Metabolomics
Informatics
Activity
NRL
PRCDM
Product
Technology & Resources
Publications
Proceedings
Patents
Others
Service
Service
Board
Schedule
Notice
News
Photo
Related Site
Contact Us
KOR
Publications
Product
Technology & Resources
Publications
Proceedings
Patents
Others
Projects :
Select
BMRC
BMRC, Japan Fund
BMRC, PRCDM
BMRC, ü
cPMTb
FRONTIER
FRONTIER, PRCDM
NRL
NRL, PRCDM
PRCDM
PRCDM,
RCTC
RCTC, BMRC
Published Dates :
Select
2006-International
2006-Domestic
2005-International
2005-Domestic
2004-International
2004-Domestic
2003-International
2003-Domestic
2007-International
2007-Domestic
Select All
·
Lee SJ, Kwon JA, Cho SA, Jarrar YB, Shin JG.
Effects of testosterone and 17-oestradiol on expression of the G protein-coupled receptor P2Y12 in megakaryocytic DAMI cells. (BMRC, PRCDM)
Platelets. 23(8):579-85 / 2012.12 [
LINK
]
2012-International
·
Song IS, Lee do Y, Shin MH, Kim H, Ahn YG, Park I, Kim KH, Kind T, Shin JG, Fiehn O, Liu KH.
Pharmacogenetics meets metabolomics: discovery of tryptophan as a new endogenous OCT2 substrate related to metformin disposition. ()
PLoS ONE. 7(5):e36637 / 2012.05 [
LINK
]
2012-International
·
Kim MH, Shin HJ, Lim SJ, Park JS, Lee SS, Song IS, Shin JG.
Inter-individual variability in OCT1 expression and its relationship with OCT1 genotype in liver samples from a Korean population. (BMRC, ü)
Drug Metab Pharmacokinet. 27(5):530-5 / 2012.11 [
LINK
]
2012-International
·
Jo JC, Lee JL, Ryu MH, Chang HM, Kim M, Lee HJ, Kim HS, Shin JG, Kim TW, Kang YK
Phase II and UGT1A1 genotype study of irinotecan dose escalation as salvage therapy for advanced gastric cancer. (PRCDM)
Br J Cancer. 106(10):1591-7 / 2012.05 [
LINK
]
2012-International
·
Seo KA, Lee SJ, Kim KB, Bae SK, Liu KH, Kim DH, Shin JG.
Ilaprazole, a new proton pump inhibitor, is primarily metabolized to ilaprazole sulfone by CYP3A4 and 3A5. (BMRC)
Xenobiotica. 42(3):278-84 / 2012.03 [
LINK
]
2012-International
·
Horne BD, Lenzini PA, Wadelius M, Jorgensen AL, Kimmel SE, Ridker PM, Eriksson N, Anderson JL, Pirmohamed M, Limdi NA, Pendleton RC, McMillin GA, Burmester JK, Kurnik D, Stein CM, Caldwell MD, Eby CS, Rane A, Lindh JD, Shin JG, Kim HS, Angchaisuksiri P, G
Pharmacogenetic warfarin dose refinements remain significantly influenced by genetic factors after one week of therapy. (BMRC)
Thromb Haemost. 107(2):232-40 / 2012.02 [
LINK
]
2012-International
·
Shon JH, Ku HY, Bae SY, Oh MK, Yeo CW, Bae SK, Shin JG.
The disposition of three phosphodiesterase type 5 inhibitors, vardenafil, sildenafil, and udenafil, is differently influenced by the CYP3A5 genotype. (BMRC)
Pharmacogenet Genomics. 21(12):820-8 / 2011.12 [
LINK
]
2011-International
·
Kim KB, Seo KA, Kim SE, Bae SK, Kim DH, Shin JG.
Simple and accurate quantitative analysis of ten antiepileptic drugs in human plasma by liquid chromatography/tandem mass spectrometry. (BMRC)
J Pharm Biomed Anal. 56(4):771-7 / 2011.12 [
LINK
]
2011-International
·
Park HS, Choi JY, Lee MJ, Park S, Yeo CW, Lee SS, Shin JG, Park BW.
Association between Genetic Polymorphisms of CYP2D6 and Outcomes in Breast Cancer Patients with Tamoxifen Treatment. (BMRC)
J Korean Med Sci. 26(8):1007-13 / 2011.08 [
LINK
]
2011-International
·
Yoo HH, Kim NS, Kim MJ, Shin D, Shin JG, Kim DH.
Enantioselective carbonyl reduction of eperisone in human liver microsomes. (BMRC)
Xenobiotica. 41(9):758-63 / 2011.09 [
LINK
]
2011-International
[prev]
11
12
13
14
15
16
17
18
19
20
[Next]
title
name
subject